Home › Compare › ADMP vs EQR

ADMP vs EQR: Dividend Comparison 2026

ADMP yields 258.06% · EQR yields 5.87%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 ADMP wins by $563.85M in total portfolio value
10 years
ADMP
ADMP
● Live price
258.06%
Share price
$0.78
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$563.90M
Annual income
$319,983,732.54
Full ADMP calculator →
EQR
EQR
● Live price
5.87%
Share price
$59.15
Annual div
$3.47
5Y div CAGR
15.8%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$47.8K
Annual income
$5,475.61
Full EQR calculator →

Portfolio growth — ADMP vs EQR

📍 ADMP pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodADMPEQR
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, ADMP + EQR cover 0 of 12 months — good coverage

Jan
—
Feb
—
Mar
—
Apr
—
May
—
Jun
—
Jul
—
Aug
—
Sep
—
Oct
—
Nov
—
Dec
—
ADMP pays
EQR pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

ADMP
Annual income on $10K today (after 15% tax)
$21,935.48/yr
After 10yr DRIP, annual income (after tax)
$271,986,172.66/yr
EQR
Annual income on $10K today (after 15% tax)
$499.01/yr
After 10yr DRIP, annual income (after tax)
$4,654.27/yr
At 15% tax rate, ADMP beats the other by $271,981,518.39/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of ADMP + EQR for your $10,000?

ADMP: 50%EQR: 50%
100% EQR50/50100% ADMP
Portfolio after 10yr
$281.97M
Annual income
$159,994,604.07/yr
Blended yield
56.74%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on EQR right now

ADMP
Analyst Ratings
3
Buy
3
Hold
1
Sell
Consensus: Buy
Altman Z
-59.7
Piotroski
3/9
EQR
Analyst Ratings
16
Buy
28
Hold
2
Sell
Consensus: Hold
Price Target
$70.35
+18.9% upside vs current
Range: $63.00 — $78.50
Altman Z
1.8
Piotroski
7/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

ADMP buys
0
EQR buys
0
No recent congressional trades found for ADMP or EQR in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricADMPEQR
Forward yield258.06% ✓5.87%
Annual dividend / share$2.00$3.47 ✓
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%15.8% ✓
Portfolio after 10y$563.90M ✓$47.8K
Annual income after 10y$319,983,732.54 ✓$5,475.61
Total dividends collected$538.16M ✓$23.0K
Payment frequencyquarterlyquarterly
SectorStockREIT
Analyst consensusBuyHold

Year-by-year: ADMP vs EQR ($10,000, DRIP)

YearADMP PortfolioADMP Income/yrEQR PortfolioEQR Income/yrGap
1← crossover$36,506$25,806.45$11,380$679.82+$25.1K → ADMP
2$127,109$88,046.91$13,014$837.25+$114.1K → ADMP
3$422,514$286,507.78$14,961$1,036.20+$407.6K → ADMP
4$1,342,148$890,057.94$17,297$1,289.22+$1.32M → ADMP
5$4,078,469$2,642,370.06$20,121$1,613.15+$4.06M → ADMP
6$11,868,198$7,504,236.72$23,561$2,030.84+$11.84M → ADMP
7$33,107,440$20,408,468.42$27,783$2,573.54+$33.08M → ADMP
8$88,631,800$53,206,838.59$33,013$3,284.39+$88.60M → ADMP
9$227,957,353$133,121,327.57$39,547$4,223.51+$227.92M → ADMP
10$563,898,101$319,983,732.54$47,791$5,475.61+$563.85M → ADMP

ADMP vs EQR: Complete Analysis 2026

ADMP — Stock

Adamis Pharmaceuticals Corporation, a specialty biopharmaceutical company, develops and commercializes products in the therapeutic areas of allergy, opioid overdose, respiratory, and inflammatory disease in the United States. The company's product candidates comprise SYMJEPI epinephrine pre-filled syringe injectable products for use in the emergency treatment of acute allergic reactions, including anaphylaxis; dry powder inhaler products for the treatment of asthma; and naloxone injection for the treatment of opioid overdose. It also offers APC400, a tempol gel use of reducing radiation dermatitis in patients undergoing treatment for cancer; and APC410 for the treatment of respiratory diseases, including asthma, respiratory syncytial virus, influenza, and COVID-19. In addition, the company provides corticosteroids, hormone replacement therapies, hospital outsourcing products, and injectables; and veterinary pharmaceutical products for animals. Adamis Pharmaceuticals Corporation was founded in 2006 and is headquartered in San Diego, California.

Full ADMP Calculator →

EQR — REIT

Equity Residential is committed to creating communities where people thrive. The Company, a member of the S&P 500, is focused on the acquisition, development and management of residential properties located in and around dynamic cities that attract high quality long-term renters. Equity Residential owns or has investments in 305 properties consisting of 78,568 apartment units, located in Boston, New York, Washington, D.C., Seattle, San Francisco, Southern California and Denver.

Full EQR Calculator →
📬

Get this ADMP vs EQR comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

ADMP vs SCHDADMP vs JEPIADMP vs OADMP vs KOADMP vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.